(1.26%) 5 128.11 points
(1.23%) 38 694 points
(1.96%) 16 152 points
(-0.81%) $78.31
(5.45%) $2.15
(-0.04%) $2 308.70
(-0.41%) $26.72
(0.38%) $966.25
(-0.37%) $0.929
(-1.17%) $10.86
(-0.10%) $0.797
(0.35%) $91.45
-10.80% $ 5.50
Live Chart Being Loaded With Signals
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve...
Stats | |
---|---|
Dzisiejszy wolumen | 24 628.00 |
Średni wolumen | 5 277.00 |
Kapitalizacja rynkowa | 120.98M |
EPS | $0 ( 2024-03-06 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.267 |
ATR14 | $0.618 (22.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-11 | Wilson Robert N | Buy | 506 | Common Stock |
2023-11-07 | Leheny A. Rachel | Buy | 2 000 | Common Stock |
2023-11-06 | Roberts Eric W | Buy | 2 400 | Common Stock |
2023-11-03 | Roberts Eric W | Buy | 11 249 | Common Stock |
2023-11-03 | Roberts Eric W | Buy | 3 700 | Common Stock |
INSIDER POWER |
---|
96.28 |
Last 97 transactions |
Buy: 3 103 303 | Sell: 60 672 |
Wolumen Korelacja
Graybug Vision, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
VKTX | 0.939 |
INFI | 0.939 |
POWW | 0.935 |
CTMX | 0.932 |
VSTA | 0.931 |
TTCF | 0.926 |
NOTV | 0.925 |
JWEL | 0.924 |
ACET | 0.918 |
COMT | 0.917 |
10 Najbardziej negatywne korelacje | |
---|---|
IMMR | -0.919 |
CCRC | -0.918 |
IBEX | -0.899 |
PBFS | -0.89 |
MGI | -0.883 |
ISIG | -0.878 |
ACLX | -0.875 |
SEDG | -0.873 |
MSON | -0.866 |
RMRM | -0.857 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Graybug Vision, Inc. Korelacja - Waluta/Towar
Graybug Vision, Inc. Finanse
Annual | 2022 |
Przychody: | $2.96M |
Zysk brutto: | $2.96M (100.00 %) |
EPS: | $-319.50 |
FY | 2022 |
Przychody: | $2.96M |
Zysk brutto: | $2.96M (100.00 %) |
EPS: | $-319.50 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.690 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-5.25 |
Financial Reports:
No articles found.
Graybug Vision, Inc.
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej